Mercer Global Advisors Inc Alx Oncology Holdings Inc Transaction History
Mercer Global Advisors Inc
- $43 Billion
- Q1 2025
A detailed history of Mercer Global Advisors Inc transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 10,077 shares of ALXO stock, worth $4,937. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,077Holding current value
$4,937% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
91Shares Held
35.3MCall Options Held
34KPut Options Held
36.9K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$4.75 Million6.44% of portfolio
-
Redmile Group, LLC San Francisco, CA3.64MShares$1.78 Million0.24% of portfolio
-
Tang Capital Management LLC San Diego, CA3.16MShares$1.55 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$1.32 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$900,5820.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $20M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...